Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
News in brief: Getac aims to take a new step towards a sustainable world by adopting SORPLAS™ from Sony Semiconductor Solutions (SSS) in its premium rugged products,beginning with the recently launc
NEW YORK,Oct. 30,2024-- As society\'s awareness of red light therapy continues to improve,the number of people who hold a wait-and-see attitude towards red light products is also expanding. For this g
LOS ANGELES,Oct. 30,2024-- Driving accidents often increase at night and in rainy or foggy conditions. How can safety in these situations be enhanced? UnlikeLiDAR or millimeter-wave radar,thermal imag
MELBOURNE,Australia,Oct. 31,2024--Yutong Bus("Yutong",SHA: 600066),a globally leading commercial vehicle manufacturer,has recently completed a battery endurance and mileage challenge of trav
SHANGHAI,Oct. 30,2024-- Hisense,a leading brand in global consumer electronics and home appliances,announced it has entered into an official partnership for the new FIFA Club World Cup™. The announce
- Developing markets in emerging economies by utilizingSCiB™*1 with long life performance in hot environments -
QINGDAO,China,Oct. 31,2024-- On October 24,the Smart Energy Sub-forum of the Third Belt and Road Energy Ministerial Conference and 2024 Asia Green and Low-Carbon Development Roundtable was held inQing
DONGGUAN,China,Oct. 31,2024--Fapon,a global leading life sciences company,is thrilled to announce its PSP CLIA reagent solution which demonstrates promising outcomes in extensive clinical validation
SHANGHAI,Oct. 28,2024-- WuXi Biologics ("WuXi Bio") (2269.HK),a leading global Contract Research,Development,and Manufacturing Organization (CRDMO),today announced the launch of WuXia™ RidG
Sindalah has welcomed its first wave of invited guests,marking the official opening of the island –NEOM\'s first destination
© OfficialAffairs
